Healthcare & Life Sciences

Eleven Therapeutics

seed

Stage

Investors

About

Eleven Therapeutics develops next-generation RNA therapeutics using an AI-driven platform combining combinatorial chemistry, sequencing, and big-data methods to optimize RNA molecule structure-activity relationships for safety, efficiency, and duration of effect.

Explore Eleven Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.